Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

NCT00869856 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped investigation of adverse events in a related clinical study

Conditions

Anemia
Chronic Renal Insufficiency

Interventions

DRUG: HX575 solution for s.c. administration

Sponsor

Sandoz